Epidemiological and Clinical Characteristics of the 178 Hemophilic Patients Enrolled in the Study
| Classifications of Patients . | No. . | Age, yr Mean ± SD (range) . |
|---|---|---|
| Type of hemophilia | ||
| A | 153 (86%) | 30 ± 17 (2-73) |
| B | 25 (14%) | 26 ± 12 (6-57) |
| Severity of hemophilia | ||
| Severe | 121 (68%) | 27 ± 15 (2-70) |
| Moderate | 19 (11%) | 23 ± 15 (4-57) |
| Mild | 38 (21%) | 40 ± 14 (17-73) |
| Type of concentrates received | ||
| Nonvirus-inactivated | 127 (71%) | 36 ± 13 (4-73) |
| Virus-inactivated | 33 (19%) | 19 ± 13 (6-57) |
| Recombinant | 18 (10%) | 5 ± 3 (2-15) |
| Classifications of Patients . | No. . | Age, yr Mean ± SD (range) . |
|---|---|---|
| Type of hemophilia | ||
| A | 153 (86%) | 30 ± 17 (2-73) |
| B | 25 (14%) | 26 ± 12 (6-57) |
| Severity of hemophilia | ||
| Severe | 121 (68%) | 27 ± 15 (2-70) |
| Moderate | 19 (11%) | 23 ± 15 (4-57) |
| Mild | 38 (21%) | 40 ± 14 (17-73) |
| Type of concentrates received | ||
| Nonvirus-inactivated | 127 (71%) | 36 ± 13 (4-73) |
| Virus-inactivated | 33 (19%) | 19 ± 13 (6-57) |
| Recombinant | 18 (10%) | 5 ± 3 (2-15) |